Open original FDA record ↗Recall record
- FDA identifier
- Z-0933-2019
- Company in FDA record
- Becton Dickinson & Co.
- FDA record creation date
- Feb 23, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Panels inoculated using certain lots of the indicator solution are demonstrating an increased occurrence of test aborts.
Source facts
- Action
- Urgent Medical Device Product Advisory letters dated 12/20/18 were sent to customers. Amended Urgent Medical Device Product Advisory letters dated 1/23/19 were also sent to customers.
- Initiated
- 2018-12-20
- Root cause
- Under Investigation by firm
- Terminated
- 2020-04-10
- Distribution
- The products were distributed to the following US states: AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, WV, and WY. The products were distributed to the following foreign countries: Argentina, Australia, Bangladesh, Belgium, Brazil, Canada, Cayman Islands, Chile, China, Columbia, Costa Rica, Dominican Republic, Ecuador, Guatemala, India, Indonesia, Japan, Korea, Malaysia, Mexico, Myanmar, New Zealand, Pakistan, Panama, Peru, Philippines, San Salvador, Singapore, Sri Lanka, Thailand, Taiwan, Uruguay, Vietnam
- Recall number
- Z-0933-2019
- Recall status
- Terminated
- CDRH record ID
- 170399
- FDA record created
- 2019-02-23
- Recall event number
- 81952